Type 1 Diabetes TrialNet
Type 1 Diabetes TrialNet is an international network of researchers who are exploring ways to prevent, delay and reverse the progression of type 1 diabetes.
TrialNet was established in response to the US Surgeon General's Report Healthy People 2010: understanding and improving health. This report identified diabetes as a national health objective for the US Nation.
In response to the report, Congress created the Diabetes Research Working Group (DRWG) to develop a plan for diabetes research. One recommendation of the DRWG was to conduct additional research studies (clinical trials) to prevent type 1 diabetes.
Professor Len Harrison and Professor Peter Colman from the institute are the Directors of one of four international TrialNet centers, funded by the National Institutes of Health, USA, and the JDRF, charged with designing and undertaking clinical trials to prevent T1D via a network of 18 collaborative sites in Australia and New Zealand.